A COPD treatment for former smokers developed by Regeneron Pharmaceuticals and Sanofi failed to meet its primary endpoint in one Phase 3 trial.
#stockmarket #breaking
COPD Drug Developed by Regeneron, Sanofi Fails Key Test – Investopedia
Related Posts
Iran war halts Qatar helium output, threatening global tech supply chains – AP News
The Iran war is tightening global tech supply chains by cutting off helium from Qatar, a key source of the…
Exxon’s $8.6 billion profit beats as record output offsets weak fuel prices – Reuters
Exxon Mobil on Friday edged past Wall Street’s third quarter profit estimate, boosted by strong oil output in its first…
Futures: Growth Bounces Off Lows, But Look At These Charts – Investor’s Business Daily
The major indexes bounced, but Palantir and many leaders still have sharp weekly losses. #stockmarket #breaking